Morgan Stanley
BMEZ icon

Morgan Stanley’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Morgan Stanley’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5M Sell
1,794,694
-144,315
-7% -$2.08M ﹤0.01% 2799
2026
Q1 		$27.8M Sell
1,939,009
-148,727
-7% -$2.21M ﹤0.01% 2643
2025
Q4 		$31.4M Buy
2,087,736
+282,035
+16% +$4.23M ﹤0.01% 2527
2025
Q3 		$26M Buy
1,805,701
+40,011
+2% +$568K ﹤0.01% 2631
2025
Q2 		$25.2M Sell
1,765,690
-1,163,761
-40% -$16.6M ﹤0.01% 2576
2025
Q1 		$43.6M Sell
2,929,451
-243,922
-8% -$3.82M ﹤0.01% 1932
2024
Q4 		$45.7M Sell
3,173,373
-244,292
-7% -$3.78M ﹤0.01% 1910
2024
Q3 		$54.1M Sell
3,417,665
-188,617
-5% -$2.97M ﹤0.01% 1754
2024
Q2 		$55.4M Sell
3,606,282
-200,807
-5% -$3.04M ﹤0.01% 1664
2024
Q1 		$62.4M Sell
3,807,089
-25,125
-0.7% -$396K 0.01% 1557
2023
Q4 		$56.1M Sell
3,832,214
-1,046,846
-21% -$14.6M ﹤0.01% 1613
2023
Q3 		$70.3M Sell
4,879,060
-223,072
-4% -$3.48M 0.01% 1293
2023
Q2 		$83.8M Sell
5,102,132
-435,108
-8% -$7.09M 0.01% 1192
2023
Q1 		$92.5M Buy
5,537,240
+67,465
+1% +$1.09M 0.01% 1101
2022
Q4 		$84.4M Sell
5,469,775
-586,467
-10% -$9.08M 0.01% 1132
2022
Q3 		$90.4M Sell
6,056,242
-143,963
-2% -$2.38M 0.01% 947
2022
Q2 		$102M Sell
6,200,205
-410,118
-6% -$7.03M 0.01% 904
2022
Q1 		$133M Buy
6,610,323
+83,213
+1% +$1.73M 0.02% 703
2021
Q4 		$166M Buy
6,527,110
+157,067
+2% +$4.05M 0.02% 636
2021
Q3 		$172M Buy
6,370,043
+151,157
+2% +$4.33M 0.02% 586
2021
Q2 		$180M Buy
6,218,886
+429,750
+7% +$11.9M 0.02% 578
2021
Q1 		$152M Buy
5,789,136
+69,987
+1% +$1.99M 0.02% 586
2020
Q4 		$164M Buy
5,719,149
+685,762
+14% +$18.2M 0.03% 535
2020
Q3 		$120M Buy
5,033,387
+1,662,415
+49% +$38.3M 0.02% 533
2020
Q2 		$70.5M Buy
3,370,972
+1,518,691
+82% +$29.9M 0.02% 689
2020
Q1 		$33.2M Buy
+1,852,281
New +$35.7M 0.01% 960

Other funds holding BMEZ

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

Morgan Stanley's BMEZ Position: Q2 2026 in Review

Morgan Stanley reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 7.4% in Q2 2026, selling an estimated $2.08M and leaving 1,794,694 shares worth $27.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2799.

Morgan Stanley first reported a position in BMEZ in Q1 2020 and has held it in 26 quarters since. The position peaked at $180M in Q2 2021. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Morgan Stanley held 1,794,694 shares of BlackRock Health Sciences Trust II worth $27.5M as of Q2 2026.
  • Morgan Stanley sold 144,315 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $2.08M.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2799 holding.
  • Morgan Stanley first reported a position in BlackRock Health Sciences Trust II in Q1 2020 and has held it in 26 quarters since.
  • Morgan Stanley's BlackRock Health Sciences Trust II position peaked at $180M in Q2 2021.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.